APO RESEARCH · REPORT
Contraceptives
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Product & engineering
Understand the product.
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Selected research
Industry Research
Contraceptives Industry Research Report 2026
Market perspective
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Read the full market overview
Report Scope
This report quantifies the global Contraceptives market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Contraceptives Market by Company
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Contraceptives Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Contraceptives Segment by End User
15–24 years
25–34 years
35–44 years
Above 44 years
Contraceptives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
Applications
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
Companies covered
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Contraceptives Market Size (2021-2032)
- 2.2.2 Global Contraceptives Sales (2021-2032)
- 2.2.3 Global Contraceptives Market Average Price (2021-2032)
- 2.3 Contraceptives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pills
- 2.3.3 Injectable
- 2.3.4 Condoms
- 2.3.5 Vaginal Rings
- 2.3.6 IUDs
- 2.3.7 Subdermal Implants
- 2.3.8 Others
- 2.4 Contraceptives by End User
- 2.4.1 Market Value Comparison by End User (2021 VS 2025 VS 2032)
- 2.4.2 15–24 years
- 2.4.3 25–34 years
- 2.4.4 35–44 years
- 2.4.5 Above 44 years
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Contraceptives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Contraceptives Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Contraceptives Revenue of Manufacturers (2021-2026)
- 3.4 Global Contraceptives Average Price by Manufacturers (2021-2026)
- 3.5 Global Contraceptives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Contraceptives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Contraceptives, Product Type & Application
- 3.8 Global Manufacturers of Contraceptives, Established Date
- 3.9 Global Contraceptives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer AG
- 4.1.1 Bayer AG Company Information
- 4.1.2 Bayer AG Business Overview
- 4.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer AG Contraceptives Product Portfolio
- 4.1.5 Bayer AG Recent Developments
- 4.2 Pfizer, Inc
- 4.2.1 Pfizer, Inc Company Information
- 4.2.2 Pfizer, Inc Business Overview
- 4.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer, Inc Contraceptives Product Portfolio
- 4.2.5 Pfizer, Inc Recent Developments
- 4.3 Teva Pharmaceutical Industries Ltd
- 4.3.1 Teva Pharmaceutical Industries Ltd Company Information
- 4.3.2 Teva Pharmaceutical Industries Ltd Business Overview
- 4.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
- 4.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.4 Merck & Co., Inc
- 4.4.1 Merck & Co., Inc Company Information
- 4.4.2 Merck & Co., Inc Business Overview
- 4.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck & Co., Inc Contraceptives Product Portfolio
- 4.4.5 Merck & Co., Inc Recent Developments
- 4.5 Actavis, Inc.
- 4.5.1 Actavis, Inc. Company Information
- 4.5.2 Actavis, Inc. Business Overview
- 4.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Actavis, Inc. Contraceptives Product Portfolio
- 4.5.5 Actavis, Inc. Recent Developments
- 4.6 Johnson & Johnson
- 4.6.1 Johnson & Johnson Company Information
- 4.6.2 Johnson & Johnson Business Overview
- 4.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Johnson & Johnson Contraceptives Product Portfolio
- 4.6.5 Johnson & Johnson Recent Developments
- 4.7 Gedeon Richter
- 4.7.1 Gedeon Richter Company Information
- 4.7.2 Gedeon Richter Business Overview
- 4.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gedeon Richter Contraceptives Product Portfolio
- 4.7.5 Gedeon Richter Recent Developments
- 4.8 Novo Nordisk A/S
- 4.8.1 Novo Nordisk A/S Company Information
- 4.8.2 Novo Nordisk A/S Business Overview
- 4.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
- 4.8.5 Novo Nordisk A/S Recent Developments
- 4.9 ZiZhu
- 4.9.1 ZiZhu Company Information
- 4.9.2 ZiZhu Business Overview
- 4.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ZiZhu Contraceptives Product Portfolio
- 4.9.5 ZiZhu Recent Developments
- 4.10 Baijingyu
- 4.10.1 Baijingyu Company Information
- 4.10.2 Baijingyu Business Overview
- 4.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Baijingyu Contraceptives Product Portfolio
- 4.10.5 Baijingyu Recent Developments
- 4.11 Huazhong
- 4.11.1 Huazhong Company Information
- 4.11.2 Huazhong Business Overview
- 4.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Huazhong Contraceptives Product Portfolio
- 4.11.5 Huazhong Recent Developments
- 4.12 Sine
- 4.12.1 Sine Company Information
- 4.12.2 Sine Business Overview
- 4.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Sine Contraceptives Product Portfolio
- 4.12.5 Sine Recent Developments
- 4.13 Reckitt
- 4.13.1 Reckitt Company Information
- 4.13.2 Reckitt Business Overview
- 4.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Reckitt Contraceptives Product Portfolio
- 4.13.5 Reckitt Recent Developments
- 4.14 AbbVie
- 4.14.1 AbbVie Company Information
- 4.14.2 AbbVie Business Overview
- 4.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AbbVie Contraceptives Product Portfolio
- 4.14.5 AbbVie Recent Developments
- 4.15 Church & Dwight
- 4.15.1 Church & Dwight Company Information
- 4.15.2 Church & Dwight Business Overview
- 4.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Church & Dwight Contraceptives Product Portfolio
- 4.15.5 Church & Dwight Recent Developments
- 4.16 The Cooper Companies
- 4.16.1 The Cooper Companies Company Information
- 4.16.2 The Cooper Companies Business Overview
- 4.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 The Cooper Companies Contraceptives Product Portfolio
- 4.16.5 The Cooper Companies Recent Developments
- 4.17 TherapeuticsMD
- 4.17.1 TherapeuticsMD Company Information
- 4.17.2 TherapeuticsMD Business Overview
- 4.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 TherapeuticsMD Contraceptives Product Portfolio
- 4.17.5 TherapeuticsMD Recent Developments
- 4.18 Afaxys
- 4.18.1 Afaxys Company Information
- 4.18.2 Afaxys Business Overview
- 4.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Afaxys Contraceptives Product Portfolio
- 4.18.5 Afaxys Recent Developments
- 4.19 Mithra Pharmaceuticals
- 4.19.1 Mithra Pharmaceuticals Company Information
- 4.19.2 Mithra Pharmaceuticals Business Overview
- 4.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
- 4.19.5 Mithra Pharmaceuticals Recent Developments
5 Global Contraceptives Market Scenario by Region
- 5.1 Global Contraceptives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Contraceptives Sales by Region: 2021-2032
- 5.2.1 Global Contraceptives Sales by Region: 2021-2026
- 5.2.2 Global Contraceptives Sales by Region: 2027-2032
- 5.3 Global Contraceptives Revenue by Region: 2021-2032
- 5.3.1 Global Contraceptives Revenue by Region: 2021-2026
- 5.3.2 Global Contraceptives Revenue by Region: 2027-2032
- 5.4 North America Contraceptives Market Facts & Figures by Country
- 5.4.1 North America Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Contraceptives Sales by Country (2021-2032)
- 5.4.3 North America Contraceptives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Contraceptives Market Facts & Figures by Country
- 5.5.1 Europe Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Contraceptives Sales by Country (2021-2032)
- 5.5.3 Europe Contraceptives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Contraceptives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Contraceptives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Contraceptives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Contraceptives Market Facts & Figures by Country
- 5.7.1 South America Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Contraceptives Sales by Country (2021-2032)
- 5.7.3 South America Contraceptives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Contraceptives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Contraceptives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Contraceptives Sales by Type (2021-2032)
- 6.1.1 Global Contraceptives Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Contraceptives Sales Market Share by Type (2021-2032)
- 6.2 Global Contraceptives Revenue by Type (2021-2032)
- 6.2.1 Global Contraceptives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Contraceptives Revenue Market Share by Type (2021-2032)
- 6.3 Global Contraceptives Price by Type (2021-2032)
7 Segment by End User
- 7.1 Global Contraceptives Sales by End User (2021-2032)
- 7.1.1 Global Contraceptives Sales by End User (2021-2032) & (M Units)
- 7.1.2 Global Contraceptives Sales Market Share by End User (2021-2032)
- 7.2 Global Contraceptives Revenue by End User (2021-2032)
- 7.2.1 Global Contraceptives Sales by End User (2021-2032) & (US$ Million)
- 7.2.2 Global Contraceptives Revenue Market Share by End User (2021-2032)
- 7.3 Global Contraceptives Price by End User (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Contraceptives Value Chain Analysis
- 8.1.1 Contraceptives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Contraceptives Production Mode & Process
- 8.2 Contraceptives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Contraceptives Distributors
- 8.2.3 Contraceptives Customers
9 Global Contraceptives Analyzing Market Dynamics
- 9.1 Contraceptives Industry Trends
- 9.2 Contraceptives Industry Drivers
- 9.3 Contraceptives Industry Opportunities and Challenges
- 9.4 Contraceptives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst